Emergence of coagulase-negative staphylococci as a cause of native valve endocarditis.

BACKGROUND Coagulase-negative staphylococci (CoNS) are an infrequent cause of native valve endocarditis (NVE), and our understanding of NVE caused by CoNS is incomplete. METHOD The International Collaboration on Endocarditis-Prospective Cohort Study includes patients with endocarditis from 61 centers in 28 countries. Patients with definite cases of NVE caused by CoNS who were enrolled during the period June 2000-August 2006 were compared with patients with definite cases of NVE caused by Staphylococcus aureus and patients with NVE caused by viridans group streptococci. Multivariable logistic regression was used to determine factors associated with death in patients with NVE caused by CoNS. RESULTS Of 1635 patients with definite NVE and no history of injection drug use, 128 (7.8%) had NVE due to CoNS. Health care-associated infection occurred in 63 patients (49%) with NVE caused by CoNS. Comorbidities, long-term intravascular catheter use, and history of recent invasive procedures were similar among patients with NVE caused by CoNS and among patients with NVE caused by S. aureus. Surgical treatment for endocarditis occurred more frequently in patients with NVE due to CoNS (76 patients [60%]) than in patients with NVE due to S. aureus (150 [33%]; P=.01) or in patients with NVE due to viridans group streptococci (149 [44%]; P=.01). Despite the high rate of surgical procedures among patients with NVE due to CoNS, the mortality rates among patients with NVE due to CoNS and among patients with NVE due to S. aureus were similar (32 patients [25%] and 124 patients [27%], respectively; P=.44); the mortality rate among patients with NVE due to CoNS was higher than that among patients with NVE due to viridans group streptococci (24 [7.0%]; P=.01). Persistent bacteremia (odds ratio, 2.65; 95% confidence interval, 1.08-6.51), congestive heart failure (odds ratio, 3.35; 95% confidence interval, 1.57-7.12), and chronic illness (odds ratio, 2.86; 95% confidence interval, 1.34-6.06) were independently associated with death in patients with NVE due to CoNS (c index, 0.73). CONCLUSIONS CoNS have emerged as an important cause of NVE in both community and health care settings. Despite high rates of surgical therapy, NVE caused by CoNS is associated with poor outcomes.

[1]  Bruno Hoen,et al.  Staphylococcus aureus endocarditis: a consequence of medical progress. , 2005, Journal of the American Medical Association (JAMA).

[2]  S. Eykyn,et al.  Increase in native valve endocarditis caused by coagulase negative staphylococci: an Anglo-French clinical and microbiological study. , 1990, British heart journal.

[3]  V. Fowler,et al.  Proposed modifications to the Duke criteria for the diagnosis of infective endocarditis. , 2000, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[4]  M. Finland,et al.  Changing etiology of bacterial endocarditis in the antibacterial era. Experiences at Boston City Hospital 1933-1965. , 1970, Annals of internal medicine.

[5]  E. Quinn,et al.  STAPHYLOCOCCUS ALBUS (EPIDERMIDIS) ENDOCARDITIS: REPORT OF 16 CASES SEEN BETWEEN 1953 AND 1962. , 1963, Antimicrobial agents and chemotherapy.

[6]  S. Goldstein,et al.  Seven cases of surgical native valve endocarditis caused by coagulase-negative staphylococci: An underappreciated disease. , 2001, American heart journal.

[7]  Samuel V. Angiuoli,et al.  Insights on Evolution of Virulence and Resistance from the Complete Genome Analysis of an Early Methicillin-Resistant Staphylococcus aureus Strain and a Biofilm-Producing Methicillin-Resistant Staphylococcus epidermidis Strain , 2005, Journal of bacteriology.

[8]  G. Peters,et al.  Pathogenesis of infections due to coagulase-negative staphylococci. , 2002, The Lancet. Infectious diseases.

[9]  A. Karchmer,et al.  Endocarditis due to coagulase-negative staphylococci. Microbiologic, epidemiologic, and clinical considerations. , 1993, Infectious disease clinics of North America.

[10]  Gilbert Habib,et al.  Native valve endocarditis due to coagulase-negative staphylococci: report of 99 episodes from the International Collaboration on Endocarditis Merged Database. , 2004, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[11]  G. Archer,et al.  The Staphylococci in Human Disease , 1996 .

[12]  J. Geraci,et al.  Endocarditis caused by coagulase-negative staphylococci. , 1968, Mayo Clinic proceedings.

[13]  C. Cabell,et al.  Progress toward a global understanding of infective endocarditis. Early lessons from the International Collaboration on Endocarditis investigation. , 2002, Infectious disease clinics of North America.

[14]  H. Rohde,et al.  Detection of Virulence-Associated Genes Not Useful for Discriminating between Invasive and Commensal Staphylococcus epidermidis Strains from a Bone Marrow Transplant Unit , 2004, Journal of Clinical Microbiology.

[15]  P. Fey,et al.  Clonal Analysis of Staphylococcus epidermidis Isolates Carrying or Lacking Biofilm-Mediating Genes by Multilocus Sequence Typing , 2005, Journal of Clinical Microbiology.

[16]  R. Gibbons,et al.  ACC/AHA Guidelines for the Management of Patients With Valvular Heart Disease. Executive Summary. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Management of Patients With Valvular Heart Disease). , 1998, The Journal of heart valve disease.

[17]  Xavier Duval,et al.  Endocarditis in patients with a permanent pacemaker: a 1-year epidemiological survey on infective endocarditis due to valvular and/or pacemaker infection. , 2004, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[18]  G. Archer,et al.  Native valve endocarditis due to coagulase-negative staphylococci. Clinical and microbiologic features. , 1987, The American journal of medicine.

[19]  R G Petersdorf,et al.  INFECTIVE ENDOCARDITIS: A REVIEW OF 125 CASES FROM THE UNIVERSITY OF WASHINGTON HOSPITALS, 1963–72 , 1977, Medicine.

[20]  D. Durack,et al.  New criteria for diagnosis of infective endocarditis: utilization of specific echocardiographic findings. Duke Endocarditis Service. , 1994, The American journal of medicine.

[21]  D. Sturdevant,et al.  Genomewide analysis of gene expression in Staphylococcus epidermidis biofilms: insights into the pathophysiology of S. epidermidis biofilms and the role of phenol-soluble modulins in formation of biofilms. , 2005, The Journal of infectious diseases.

[22]  H. O'Shields,et al.  Coagulase-Negative Staphylococcal Endocarditis: A View From the Community Hospital , 1986, Southern medical journal.

[23]  Daniel J Sexton,et al.  Health CareAssociated Bloodstream Infections in Adults: A Reason To Change the Accepted Definition of Community-Acquired Infections , 2002, Annals of Internal Medicine.

[24]  D Lacroix,et al.  Systemic infection related to endocarditis on pacemaker leads: clinical presentation and management. , 1997, Circulation.

[25]  N. Arber,et al.  Native valve Staphylococcus epidermidis endocarditis: report of seven cases and review of the literature. , 1991, The American journal of medicine.

[26]  杜昕,et al.  Infective endocarditis , 2007 .